MentionFox
Home › Executive changes › Johnson & Johnson
Leadership changes · JNJ · SEC Form 8-K, Item 5.02

Leadership changes at Johnson & Johnson (2026)

Before you join, sell to or invest in Johnson & Johnson

MentionFox check on Johnson & Johnson: only 2 sources on file so far (checked 6 November 2026). Run a full check before you rely on it. mentionfox.com/c/executive-changes/johnson-and-johnson

  • Note: Layoff notice filed May 2026 (about 86 employees in NJ) (state notice)

Check Johnson & Johnson before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Johnson & Johnson?

Who joined and who left Johnson & Johnson (JNJ)? 1 filing reported on 2026-08-04, each cited to the company's own filing.

As of November 6, 2026, Johnson & Johnson has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on August 4, 2026 (Form 8-K, August 4, 2026).

30 companies changed executives this week.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

John Hancock Comvest Private Income Fundnamed a new Chief Financial Officer
Bain Capital Specialty Finance, Inc.named a new Director
Azora Therapeutics, Inc. (DE)named a new Director
LASE Corp.named a new Director
Century Communities, Inc.named a new Executive Chairman
Check one company free

Vanguard Capital Management also filed stake reports on 1495 other companies ↓

Sell to companies like Johnson & Johnson? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Changes1
Latest filing2026-08-04

Johnson & Johnson reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-08-04. Every row below is cited to the filing it comes from, and this page adds each new change as Johnson & Johnson files it.

Also on the record for Johnson & Johnson

DateRecordFigureOur pageSource
May 1, 2026Stake report, Schedule 13G, by Vanguard Capital Management7.49% of the class5%+ stakesSource
March 26, 2026Stake report, Schedule 13G/A, by The Vanguard Group—5%+ stakesSource
February 5, 2026Stake report, Schedule 13G/A, by The Vanguard Group10.1% of the class5%+ stakesSource

Selling to them or working with them? See who runs Johnson & Johnson now and the warning signs.

Free to see. No signup.

Keep reading

More on Johnson & Johnson and the records around it.

Companies that share a holder

Want the whole picture on Johnson & Johnson?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Johnson & Johnson: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Johnson & Johnson covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    5 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-08-04Reportednot named in the filing8-K, 2026-08-04
Selling to Johnson & Johnson?

New leaders reset buying decisions — get the Full Report on Johnson & Johnson: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch Johnson & Johnson

Hiring for a seat like this?

Find people with the same kind of experience as the senior executive at Johnson & Johnson, with the record behind each one.

Find candidates like senior executive at Johnson & Johnson

Every change, in the filing's words

Filed 2026-08-04 · 8-K

Reported

On August 4, 2026, the Company announced that Jennifer Taubert will retire from her position as Executive Vice President, Worldwide Chairman, Innovative Medicine and member of the Executive Committee effective September 1, 2026.

Tools for this story

Each opens in a new tab, filled in for Johnson & Johnson. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/johnson-and-johnson
Last updated 2026-11-06
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4 · New Jersey WARN file
What changed at the top of Johnson & Johnson? (2026). MentionFox, 2026-11-06. https://mentionfox.com/executive-changes/johnson-and-johnson